Bobby Green Receives 6-Month Suspension From USADA for DHEA

Bobby Green Accepts Sanction for Violation of UFC Anti-Doping Policy https://t.co/InKZkG7wPJ

— USADA (@usantidoping) October 7, 2022

Ultimate Fighting Championship lightweight Bobby Green will be forced to sit out for another month before he can compete again.

The U.S. Anti-Doping Agency announced on Thursday that Green has been issued a suspension after his positive test for an anabolic steroid after an out-of-competition test. He was flagged in May 2022, which is when the six-month suspension will be applied. Green will be eligible to return to competition starting Nov. 16. While Green could have received a lengthier sentence, per the agency, his cooperation and provided documentation reduced it.

Green contested that he purchased a supplement of dehydroepiandrosterone (DHEA) – a substance that fighters like Lyoto Machida have encountered in past UFC instances – at a local Walmart, according to TSN’s report of a past Instagram posting by Green. The substance was purchased legally as an over-the-counter product from the store. When USADA concluded its investigation, it found that Green’s level of fault was less severe to merit a lower suspension.

USADA's statement regarding Green reads as follows:

”USADA announced today that Bobby Green, of Apple Valley, Calif. has accepted a six-month sanction for a violation of the UFC® Anti-Doping Policy.

“Green, 36, tested positive for the presence of an anabolic androgenic steroid of exogenous origin as the result of a urine sample collected out-of-competition on May 16, 2022. Exogenous anabolic androgenic steroids are Non-Specified Substances in the class of Anabolic Agents and are prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.

“During an investigation into the circumstances of the case, Green provided evidence that he purchased dehydroepiandrosterone (DHEA) as an over-the-counter supplement product at a local retailer. In the U.S., unlike other countries, DHEA can be legally sold as a dietary supplement and is different from other anabolic agents that are regulated as controlled substances. Under the Policy, USADA may also consider the degree of performance enhancement when determining the athlete’s level of fault, and in this case, considered the athlete’s brief use of the supplement.

“Given these factors, USADA determined that Green’s degree of fault was diminished and that he should receive a reduced period of ineligibility. He also received a reduction for his Full and Complete Cooperation.”